バイオ手術の世界市場予測(~2026年):製品種類別(シーラント、止血鉗子、接着バリア、軟組織アタッチメント、生物学的メッシュ、DBM、骨移植代替物)、用途別(整形手術、心臓血管)、エンドユーザー別(病院、クリニック)

◆英語タイトル:Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) - Global Forecast to 2026
◆商品コード:MD3554
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年6月21日
◆ページ数:376
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社はバイオ手術の世界市場規模が2021年122億ドルから2026年160億ドルまで、年平均5.7%成長すると予想しています。本書では、世界のバイオ手術市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、製品別(骨移植代替物、軟部組織付属品、止血剤、手術用シーラント・接着剤、癒着障壁)分析、用途別(整形手術、一般手術、脳神経手術、心臓血管手術、再建手術)分析、エンドユーザー別(病院、クリニック、その他)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業インサイト
・バイオ手術の世界市場規模:製品別(骨移植代替物、軟部組織付属品、止血剤、手術用シーラント・接着剤、癒着障壁)
・バイオ手術の世界市場規模:用途別(整形手術、一般手術、脳神経手術、心臓血管手術、再建手術)
・バイオ手術の世界市場規模:エンドユーザー別(病院、クリニック、その他)
・バイオ手術の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The biosurgery market is projected to reach USD 16.0billion by 2026 from USD 12.2billion in 2021, at a CAGR of 5.7% during the forecast period.”
Growth in this market is majorly driven by the growing prevalence of chronic diseases requiring surgical interventions and severe traumatic injuries. Owing to increasing growth in such incidence, the volume of elective surgical procedures is increasing, which is driving the demand for biosurgery products. In addition, rising demand for effective blood loss management and increasing availability of advanced biosurgery products is also helping to back the market growth. However, high cost of biosurgery products, dearth of skilled professionals, and stringent regulatory framework are expected to hamper the growth of this market during the forecast period.

“Based on product, the bone graft substitutes holds the largest market share during the forecast period.”
Based on the product, the bone graft substitutes segment accounted for the largest share of the global biosurgery market in 2020. Bone-graft substitutes are alternative products to autografts and possess osteoconductive properties. Although autografts are used as the gold standard for the treatment of bone defects, they have various limitations, such as the potential risk of infections and donor site morbidity. As a result, the focus on new orthobiologic materials like synthetic bone-graft substitutes is increasing. Moreover, the use of bone graft substitutes eliminates the need for a second operative procedure and an extra incision at the site of the surgery. As a result, the adoption of bone graft substitutes such as demineralized bone matrix, synthetic bone grafts, allografts, and bone morphogenetic proteins is increasing across orthopedic and dental surgeries globally.

“Based onapplication, thereconstructive surgery segment is expected to register the highest CAGR during the forecast period.”
The reconstructive surgery in the application segment is expected to show the highest growth rate during the forecast period. Surgical sealants, hemostats, soft-tissue patches/meshes, and staple line reinforcement agents are extensively used in various reconstructive surgeries, including plastic surgeries, facelifts, rhinoplasty, body contouring, breast surgeries (breast reconstruction & augmentation), burns, and craniofacial applications. Rising number of surgical reconstructive procedures such as facial reconstruction and minimally invasive cosmetic procedures, increasing incidence of skin injuries, growing incidence of burn injuries, and the increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures are driving the rapid adoption of biosurgery products in the reconstructive surgery segment.

“Based on end-user, the hospitals segment holds the largest market share during the forecast period.”
The biosurgery market is segmented into hospitals, clinics,and others. The hospital segment dominates the market share in 2020. The biosurgery products are extensively used in hospitals across operating rooms during surgeries. Moreover, the use of soft-tissue attachments and bone-graft substitutes (such as DBM and BMP) is increasing across hospitals to reduce the duration of patient stays and enhance the healing process. Bone-graft substitutes are finding use as osteoconductive and osteoinductive materials, specifically across orthopedic and spinal procedures. Similarly, hemostatic agents and adhesion barriers are finding increasing adoption across abdominal and cardiovascular procedures to prevent post-operative complications. Moreover, the number of hospitals is increasing globally, especially in emerging countries, which is supporting the high revenue growth in the segment.

“North America accounted for the largest share of the biosurgerymarket in 2020.”
In 2020, North America accounted for the largest share of the biosurgerymarket, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of this market segment can be attributed to the presence of a significant number of prominent vendors, a highly developed healthcare system, increasing volume of elective surgeries, rising prevalence of chronic diseases, and favorable reimbursement policies for biosurgery products.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, AsiaPacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the biosurgery market:
The key players operating in the biosurgerymarketinclude Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK).

Research Coverage:
The report analyzes the biosurgerymarketand aims at estimating the market size and future growth potential of this market based on various segments such asproduct, application, end user,andregion. The report also includes aproduct portfolio matrix of various biosurgery productsavailable in the market. The report also providesa competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would helpthem, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies tostrengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global biosurgerymarket. The report analyzes this marketbyproduct, application, and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and productlaunches in the global biosurgerymarket.
• Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in theglobal biosurgerymarket.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in theglobal biosurgerymarket.

【レポートの目次】

1 INTRODUCTION 50
1.1 OBJECTIVES OF THE STUDY 50
1.2 MARKET DEFINITION & SCOPE 50
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 51
1.2.2 MARKET SEGMENTATION 52
FIGURE 1 BIOSURGERY MARKET SEGMENTATION 52
1.2.3 YEARS CONSIDERED FOR THE STUDY 53
1.3 CURRENCY 53
1.4 STAKEHOLDERS 54
1.5 SUMMARY OF CHANGES 54
2 RESEARCH METHODOLOGY 56
2.1 RESEARCH APPROACH 56
2.2 RESEARCH METHODOLOGY DESIGN 56
2.2.1 SECONDARY RESEARCH 56
2.2.1.1 Key data from secondary sources 57
2.2.2 PRIMARY DATA 58
FIGURE 2 PRIMARY SOURCES 58
2.2.2.1 Key data from primary sources 59
2.2.2.2 Insights from primary experts 59
2.2.2.3 Breakdown of primary interviews: Supply-side and demand-side participants 60
2.2.2.4 Breakdown of primary interviews: By company, designation, and region 60
2.3 MARKET SIZE ESTIMATION: BIOSURGERY MARKET 61
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 61
FIGURE 4 REVENUE SHARE ANALYSIS ILLUSTRATION—BAXTER INTERNATIONAL, INC. 62
FIGURE 5 REVENUE ANALYSIS OF THE TOP 3 PUBLIC COMPANIES: SURGICAL SEALANTS AND ADHESIVES SEGMENT (2020) 63
FIGURE 6 BOTTOM-UP APPROACH—SEGMENTAL EXTRAPOLATION 64
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE BIOSURGERY MARKET
(2021–2026) 65
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 67
2.5 MARKET SHARE ESTIMATION 67
2.6 ASSUMPTIONS FOR THE STUDY 68
2.7 LIMITATIONS 68
2.7.1 METHODOLOGY-RELATED LIMITATIONS 68
2.8 RISK ASSESSMENT 69
TABLE 1 RISK ASSESSMENT: BIOSURGERY MARKET 69
3 EXECUTIVE SUMMARY 70
FIGURE 10 BIOSURGERY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 70
FIGURE 11 BIOSURGERY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 71
FIGURE 12 BIOSURGERY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 72
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE BIOSURGERY MARKET 73
4 PREMIUM INSIGHTS 74
4.1 BIOSURGERY MARKET OVERVIEW 74
FIGURE 14 INCREASING NEED TO MANAGE BLOOD LOSS IN PATIENTS AND FOCUS ON THE LAUNCH OF NEW PRODUCTS TO DRIVE MARKET GROWTH 74
4.2 ASIA PACIFIC: BIOSURGERY MARKET FOR NATURAL SEALANTS & ADHESIVES,
BY TYPE AND COUNTRY (2020) 75
FIGURE 15 FIBRIN-BASED SEALANTS & ADHESIVES SEGMENT ACCOUNTED FOR
THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 75
4.3 BIOSURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 76
FIGURE 16 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD 76
4.4 BIOSURGERY MARKET, BY REGION (2019–2026) 77
FIGURE 17 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOSURGERY MARKET DURING THE FORECAST PERIOD 77
4.5 BIOSURGERY MARKET: DEVELOPED VS. DEVELOPING MARKETS 77
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 77
5 MARKET OVERVIEW 78
5.1 INTRODUCTION 78
5.2 MARKET DYNAMICS 78
5.2.1 MARKET DRIVERS 79
5.2.1.1 Increasing volume of surgeries and growing prevalence of severe trauma injuries 79
TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED 79
5.2.1.2 Strong focus on R&D leading to the launch of technologically advanced products 80
5.2.1.3 Rising need for effective blood loss management in patients 81
5.2.2 MARKET RESTRAINTS 81
5.2.2.1 High price of biosurgery products and the rising cost of surgical procedures 81
5.2.3 MARKET OPPORTUNITIES 82
5.2.3.1 Growing use of combination materials for enhancing product efficacy 82
5.2.3.2 Growing adoption of advanced biosurgery products in emerging markets 82
TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD) 83
5.2.3.3 Growing adoption of adhesive dentistry procedures 83
5.2.4 MARKET CHALLENGES 84
5.2.4.1 Stringent regulatory framework 84
5.2.4.2 Requirement of skilled personnel for the effective use of biosurgery products 84
6 INDUSTRY INSIGHTS 86
6.1 INTRODUCTION 86
6.2 INDUSTRY TRENDS 86
6.2.1 GROWING FOCUS ON ORGANIC GROWTH STRATEGIES 86
TABLE 4 NUMBER OF PRODUCT LAUNCHES BY KEY PLAYERS (JANUARY 2018 TO JUNE 2021) 86
6.2.2 GROWING DEMAND FOR DENTAL BONE-GRAFT SUBSTITUTES 87
6.2.3 GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES & HYDROGELS IN SURGICAL PROCEDURES 87
6.2.4 USE OF NANOTECHNOLOGY FOR DEVELOPING NEXT-GENERATION ADHESIVES 88
6.3 REGULATORY ANALYSIS 89
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING BIOSURGERY PRODUCTS 89
6.3.1 NORTH AMERICA 89
6.3.1.1 US 89
TABLE 6 US FDA: CLASSIFICATIONS OF MEDICAL DEVICES 90
FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 91
6.3.1.2 Canada 91
FIGURE 20 CANADA: CLASS III MEDICAL DEVICES APPROVAL PROCESS 91
6.3.2 EUROPE 92
FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR BIOSURGERY PRODUCTS 92
6.3.3 ASIA PACIFIC 92
6.3.3.1 Japan 92
TABLE 7 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 93
6.3.3.2 China 93
TABLE 8 NMPA MEDICAL DEVICES CLASSIFICATION 93
6.3.3.3 India 94
TABLE 9 INDIA: CLASSIFICATION OF BIOSURGERY PRODUCTS 94
6.4 PORTER’S FIVE FORCES ANALYSIS 94
TABLE 10 PORTER’S FIVE FORCES ANALYSIS 94
6.4.1 THREAT OF NEW ENTRANTS 95
6.4.2 THREAT OF SUBSTITUTES 95
6.4.3 BARGAINING POWER OF SUPPLIERS 95
6.4.4 BARGAINING POWER OF BUYERS 95
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 96
6.5 PRICING ANALYSIS 96
TABLE 11 AVERAGE SELLING PRICE FOR BIOSURGERY PRODUCTS 97
6.6 TECHNOLOGY ANALYSIS 97
6.7 ECOSYSTEM ANALYSIS 98
FIGURE 22 BIOSURGERY MARKET: ECOSYSTEM ANALYSIS 98
6.8 VALUE CHAIN ANALYSIS 98
FIGURE 23 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING
THE MANUFACTURING PHASE 99
6.9 PATENT ANALYSIS 99
6.9.1 PATENT PUBLICATION TRENDS FOR BIOSURGERY 99
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021) 100
6.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 100
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BIOSURGERY PATENTS (JANUARY 2011 TO JUNE 2021) 101
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR BIOSURGERY PATENTS
(JANUARY 2011 TO JUNE 2021) 102
TABLE 12 LIST OF FEW PATENTS IN THE BIOSURGERY MARKET, 2020–2021 102
6.10 COVID-19 IMPACT ON THE BIOSURGERY MARKET 103
7 BIOSURGERY MARKET, BY PRODUCT 105
7.1 INTRODUCTION 106
TABLE 13 BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 106
7.2 BONE-GRAFT SUBSTITUTES 106
TABLE 14 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 15 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 107
7.2.1 DEMINERALIZED BONE MATRIX 108
7.2.1.1 DBM is used extensively as a void filler in joint reconstruction and spinal fusion procedures 108
TABLE 16 MAJOR PRODUCTS IN THE DBM MARKET 108
TABLE 17 DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
7.2.2 SYNTHETIC BONE GRAFTS 109
7.2.2.1 Development of standard materials for synthetic bone grafts to drive the growth of this market segment 109
TABLE 18 MAJOR PRODUCTS IN THE SYNTHETIC BONE GRAFTS MARKET 110
TABLE 19 SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 111
7.2.3 BONE MORPHOGENETIC PROTEINS 111
7.2.3.1 Regulatory approval for the use of BMP in spinal fusion procedures to drive the growth of this market segment 111
TABLE 20 MAJOR PRODUCTS IN THE BONE MORPHOGENETIC PROTEINS MARKET 112
TABLE 21 BONE MORPHOGENETIC PROTEINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
7.2.4 OTHER BONE-GRAFT SUBSTITUTES 113
TABLE 22 MAJOR PRODUCTS IN THE OTHER BONE-GRAFT SUBSTITUTES MARKET 114
TABLE 23 OTHER BONE-GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114

7.3 SOFT-TISSUE ATTACHMENTS 115
TABLE 24 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 25 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 116
7.3.1 SYNTHETIC MESHES 116
7.3.1.1 Vendors are focusing on developing new composite synthetic meshes to gain a competitive edge 116
TABLE 26 MAJOR PRODUCTS IN THE SYNTHETIC MESHES MARKET 117
TABLE 27 SYNTHETIC MESHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
7.3.2 BIOLOGICAL MESHES 118
TABLE 28 MAJOR PRODUCTS IN THE BIOLOGICAL MESHES MARKET 119
TABLE 29 BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 30 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
7.3.2.1 Allografts 120
7.3.2.1.1 Advancements in deriving products from new allograft sources to drive market growth 120
TABLE 31 ALLOGRAFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
7.3.2.2 Xenografts 121
7.3.2.2.1 Efficacy of xenografts against allografts is not proven 121
TABLE 32 XENOGRAFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
7.4 HEMOSTATIC AGENTS 122
TABLE 33 MAJOR PRODUCTS IN THE HEMOSTATIC AGENTS MARKET 123
TABLE 34 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 35 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.4.1 THROMBIN-BASED HEMOSTATIC AGENTS 124
7.4.1.1 Developments in recombinant thrombin products to support the growth of this market segment 124
TABLE 36 MAJOR PRODUCTS IN THE THROMBIN-BASED HEMOSTATIC AGENTS MARKET 125
TABLE 37 THROMBIN-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.4.2 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS 126
7.4.2.1 Vendors are expanding the availability of their ORC-based hemostatic agents across untapped markets in APAC 126
TABLE 38 MAJOR PRODUCTS IN THE OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET 126
TABLE 39 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
7.4.3 COMBINATION HEMOSTATIC AGENTS 127
7.4.3.1 Advancements in combination materials would contribute to the growth of this market segment 127
TABLE 40 MAJOR PRODUCTS IN THE COMBINATION HEMOSTATIC AGENTS MARKET 128
TABLE 41 COMBINATION HEMOSTATIC AGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.5 SURGICAL SEALANTS & ADHESIVES 129
TABLE 42 BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES,
BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 43 BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES,
BY COUNTRY, 2019–2026 (USD MILLION) 130
7.5.1 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES 130
7.5.1.1 Natural/biological sealants & adhesives, by type 130
TABLE 44 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS & ADHESIVES, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 45 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS & ADHESIVES, BY COUNTRY, 2019–2026 (USD MILLION) 131
7.5.1.1.1 Fibrin-based sealants & adhesives 132
7.5.1.1.1.1 Fibrin-based sealants & adhesives to dominate the market during the forecast period 132
TABLE 46 MAJOR PRODUCTS IN THE FIBRIN-BASED SEALANTS & ADHESIVES MARKET 132
TABLE 47 FIBRIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
7.5.1.1.2 Collagen-based sealants & adhesives 133
7.5.1.1.2.1 Low-cost and reduced risk of disease transmission are promoting the adoption of collagen-based sealants & adhesives 133
TABLE 48 MAJOR PRODUCTS IN THE COLLAGEN BASED-SEALANTS & ADHESIVES MARKET 134
TABLE 49 COLLAGEN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.5.1.1.3 Gelatin-based sealants & adhesives 135
7.5.1.1.3.1 Combination products are creating promising growth opportunities for gelatin-based sealants & adhesives 135
TABLE 50 MAJOR PRODUCTS IN THE GELATIN BASED-SEALANTS & ADHESIVES MARKET 136
TABLE 51 GELATIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
7.5.1.1.4 Albumin-based sealants 137
7.5.1.1.4.1 Adoption of albumin-based sealants & adhesives is increasing in cardiovascular and cardiothoracic procedures 137
TABLE 52 MAJOR PRODUCTS IN THE ALBUMIN BASED-SEALANTS & ADHESIVES MARKET 137
TABLE 53 ALBUMIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
7.5.1.1.5 Other natural/biological sealants & adhesives 138
TABLE 54 OTHER NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 139
7.5.1.2 Natural/biological sealants & adhesives, by origin 140
TABLE 55 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN,
2019–2026 (USD MILLION) 140
7.5.1.2.1 Animal-based sealants & adhesives 140
7.5.1.2.1.1 Animal-based sealants and adhesives are not intended for intravascular and cerebrovascular repair due to the risk of disease transfer 140
TABLE 56 ANIMAL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
7.5.1.2.2 Human blood-based sealants & adhesives 141
7.5.1.2.2.1 Human blood-based sealants are finding significant applications in endovascular and laparoscopic vascular procedures 141
TABLE 57 HUMAN BLOOD-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
7.5.2 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES 142
TABLE 58 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 59 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 143
7.5.2.1 PEG hydrogel-based sealants & adhesives 144
7.5.2.1.1 Rapid sealing abilities of PEG hydrogels to drive their adoption in spinal surgeries 144
TABLE 60 MAJOR PRODUCTS IN THE PEG HYDROGEL-BASED SEALANTS & ADHESIVES MARKET 145
TABLE 61 PEG HYDROGEL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
7.5.2.2 Cyanoacrylate-based sealants & adhesives 146
7.5.2.2.1 Cyanoacrylate-based sealants are preferred in dermatology and plastic surgeries 146
TABLE 62 MAJOR PRODUCTS IN THE CYANOACRYLATE-BASED SEALANTS & ADHESIVES MARKET 146
TABLE 63 CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 147
7.5.2.3 Urethane-based sealants & adhesives 147
7.5.2.3.1 Urethane-based sealants can be used across wet environments 147
TABLE 64 URETHANE-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 148
7.5.2.4 Other synthetic and semi-synthetic sealants & adhesives 148
TABLE 65 MAJOR PRODUCTS IN THE OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET 149
TABLE 66 OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 149
7.6 ADHESION BARRIERS 150
TABLE 67 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 68 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY COUNTRY,
2019–2026 (USD MILLION) 150
7.6.1 SYNTHETIC ADHESION BARRIERS 151
TABLE 69 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 70 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
7.6.1.1 Hyaluronic acid-based adhesion barriers 152
7.6.1.1.1 Hyaluronic acid-based adhesion barriers dominate the synthetic adhesion barriers market 152
TABLE 71 MAJOR PRODUCTS IN THE HYALURONIC ACID-BASED ADHESION BARRIERS MARKET 153
TABLE 72 HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 153
7.6.1.2 Regenerated cellulose-based adhesion barriers 154
7.6.1.2.1 Regenerated cellulose-based adhesion barriers are finding increasing use in C-section surgeries 154
TABLE 73 MAJOR PRODUCTS IN THE REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET 154
TABLE 74 REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 155
7.6.1.3 PEG-based adhesion barriers 155
7.6.1.3.1 Demand for PEG-based adhesion barriers is driven
by the rising number of peritoneal and abdominal surgeries 155
TABLE 75 MAJOR PRODUCTS IN THE PEG-BASED ADHESION BARRIERS MARKET 155
TABLE 76 PEG-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
7.6.1.4 Other synthetic adhesion barriers 156
TABLE 77 MAJOR PRODUCTS IN THE OTHER SYNTHETIC ADHESION BARRIERS MARKET 157
TABLE 78 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
7.6.2 NATURAL ADHESION BARRIERS 158
TABLE 79 NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 80 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
7.6.2.1 Collagen and protein adhesion barriers 159
7.6.2.1.1 Collagen and protein adhesion barriers to dominate the natural adhesion barriers market during the forecast period 159
TABLE 81 MAJOR PRODUCTS IN THE COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET 159
TABLE 82 COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 160
7.6.2.2 Fibrin-based adhesion barriers 160
7.6.2.2.1 Fibrin-based adhesion barriers are finding increasing applications in laparotomy procedures 160
TABLE 83 MAJOR PRODUCTS IN THE FIBRIN-BASED ADHESION BARRIERS MARKET 160
TABLE 84 FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
7.7 STAPLE-LINE REINFORCEMENT AGENTS 161
7.7.1 RISING FOCUS ON SEALANTS AND HEMOSTATS MAY RESTRAIN THE GROWTH OF THIS MARKET 161
TABLE 85 MAJOR PRODUCTS IN THE STAPLE-LINE REINFORCEMENT AGENTS MARKET 162
TABLE 86 BIOSURGERY MARKET FOR STAPLE-LINE REINFORCEMENT AGENTS,
BY COUNTRY, 2019–2026 (USD MILLION) 162
8 BIOSURGERY MARKET, BY APPLICATION 163
8.1 INTRODUCTION 164
TABLE 87 BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 164
8.2 ORTHOPEDIC SURGERY 164
8.2.1 ORTHOPEDIC SURGERY IS THE LARGEST APPLICATION SEGMENT FOR BIOSURGERY PRODUCTS 164
TABLE 88 BIOSURGERY MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 165
8.3 GENERAL SURGERY 166
8.3.1 INCREASING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE
THE GROWTH OF THIS APPLICATION SEGMENT 166
TABLE 89 BIOSURGERY MARKET FOR GENERAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 167
8.4 NEUROLOGICAL SURGERY 167
8.4.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 167
TABLE 90 BIOSURGERY MARKET FOR NEUROLOGICAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 168
8.5 CARDIOVASCULAR SURGERY 169
8.5.1 BIOSURGERY PRODUCTS ARE INCREASINGLY REPLACING CONVENTIONAL SUTURE-BASED METHODS IN CARDIOVASCULAR PROCEDURES 169
TABLE 91 BIOSURGERY MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2019–2026 (USD MILLION) 170
8.6 RECONSTRUCTIVE SURGERY 170
8.6.1 SOFT-TISSUE ATTACHMENT PRODUCTS ARE FINDING INCREASING USE IN BREAST AUGMENTATION AND RECONSTRUCTIVE PROCEDURES 170
TABLE 92 BIOSURGERY MARKET FOR RECONSTRUCTIVE SURGERY, BY COUNTRY, 2019–2026 (USD MILLION) 171
8.7 GYNECOLOGICAL SURGERY 172
8.7.1 BIOSURGERY PRODUCTS ARE OFFERING PROMISING POTENTIAL IN C-SECTION SURGERIES 172
TABLE 93 C-SECTION SURGERIES PER 1,000 BIRTHS (2018 OR LATEST AVAILABLE) 172
TABLE 94 BIOSURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 173
8.8 UROLOGICAL SURGERY 173
8.8.1 USE OF BIOSURGERY PRODUCTS IN COMPLEX RECONSTRUCTIVE UROLOGICAL SURGERIES TO STIMULATE SEGMENT GROWTH 173
TABLE 95 BIOSURGERY MARKET FOR UROLOGICAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 174
8.9 THORACIC SURGERY 175
8.9.1 GROWTH IN THIS APPLICATION SEGMENT IS DRIVEN BY THE INCREASING INCIDENCE OF PULMONARY DISEASES AND LUNG CANCER 175
TABLE 96 BIOSURGERY MARKET FOR THORACIC SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 175
8.10 OTHER APPLICATIONS 176
TABLE 97 BIOSURGERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 177
9 BIOSURGERY MARKET, BY END USER 178
9.1 INTRODUCTION 179
TABLE 98 BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 179
9.2 HOSPITALS 179
9.2.1 HOSPITALS ARE THE LARGEST END USERS OF BIOSURGERY PRODUCTS 179
TABLE 99 BIOSURGERY MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 180
9.3 CLINICS 181
9.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS 181
TABLE 100 BIOSURGERY MARKET FOR CLINICS, BY COUNTRY,
2019–2026 (USD MILLION) 182
9.4 OTHER END USERS 182
TABLE 101 BIOSURGERY MARKET FOR OTHER END USERS, BY COUNTRY,
2019–2026 (USD MILLION) 183
10 BIOSURGERY MARKET, BY REGION 184
10.1 INTRODUCTION 185
FIGURE 27 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS 185
TABLE 102 BIOSURGERY MARKET, BY REGION, 2019–2026 (USD MILLION) 186
10.2 NORTH AMERICA 187
FIGURE 28 NORTH AMERICA: BIOSURGERY MARKET SNAPSHOT 187
TABLE 103 NORTH AMERICA: BIOSURGERY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 188
TABLE 104 NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 188
TABLE 105 NORTH AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 106 NORTH AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 107 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 108 NORTH AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 109 NORTH AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 110 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 111 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 190
TABLE 112 NORTH AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 113 NORTH AMERICA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 114 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 115 NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 116 NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 192
TABLE 117 NORTH AMERICA: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 192
10.2.1 US 192
10.2.1.1 US to dominate the North American biosurgery market during the forecast period 192
TABLE 118 US: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 193
TABLE 119 US: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 120 US: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 121 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 122 US: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 123 US: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 124 US: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 125 US: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 195
TABLE 126 US: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 127 US: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 128 US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 129 US: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 130 US: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 197
TABLE 131 US: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 197
10.2.2 CANADA 198
10.2.2.1 Growing geriatric population and the increasing volume of surgeries to drive the demand for biosurgery products in Canada 198
TABLE 132 CANADA: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 198
TABLE 133 CANADA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 134 CANADA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 135 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 136 CANADA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 137 CANADA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 138 CANADA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 139 CANADA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 200
TABLE 140 CANADA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 141 CANADA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 142 CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 143 CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 144 CANADA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 202
TABLE 145 CANADA: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 202
10.3 EUROPE 203
TABLE 146 EUROPE: BIOSURGERY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 203
TABLE 147 EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 148 EUROPE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 149 EUROPE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 150 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 151 EUROPE: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 152 EUROPE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 153 EUROPE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 154 EUROPE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 206
TABLE 155 EUROPE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 156 EUROPE: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 157 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 158 EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 159 EUROPE: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 208
TABLE 160 EUROPE: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 208
10.3.1 GERMANY 208
10.3.1.1 Germany dominated the European biosurgery market in 2020 208
TABLE 161 GERMANY: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 209
TABLE 162 GERMANY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 163 GERMANY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 164 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 165 GERMANY: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 166 GERMANY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 167 GERMANY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 168 GERMANY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 211
TABLE 169 GERMANY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 170 GERMANY: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 171 GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 172 GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 173 GERMANY: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 213
TABLE 174 GERMANY: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 213
10.3.2 UK 213
10.3.2.1 Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth 213
TABLE 175 UK: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 214
TABLE 176 UK: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 177 UK: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 178 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 179 UK: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 180 UK: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 215
TABLE 181 UK: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 182 UK: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 216
TABLE 183 UK: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 184 UK: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 185 UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 217
TABLE 186 UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 217
TABLE 187 UK: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 218
TABLE 188 UK: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 218
10.3.3 FRANCE 218
10.3.3.1 Presence of a well-established healthcare system and growing geriatric population to boost market growth 218
TABLE 189 FRANCE: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 219
TABLE 190 FRANCE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 191 FRANCE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 192 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 193 FRANCE: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 194 FRANCE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 195 FRANCE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 196 FRANCE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 221
TABLE 197 FRANCE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 198 FRANCE: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 199 FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 200 FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 201 FRANCE: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 223
TABLE 202 FRANCE: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 223
10.3.4 ITALY 223
10.3.4.1 Increasing volume of surgeries to drive the demand for biosurgery products in the country 223
TABLE 203 ITALY: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 224
TABLE 204 ITALY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 205 ITALY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 206 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 207 ITALY: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 208 ITALY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 225
TABLE 209 ITALY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 210 ITALY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 226
TABLE 211 ITALY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 212 ITALY: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 213 ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 214 ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 215 ITALY: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 228
TABLE 216 ITALY: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 228
10.3.5 SWITZERLAND 228
10.3.5.1 Increasing public health insurance coverage to drive the number of surgical procedures 228
TABLE 217 SWITZERLAND: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 229
TABLE 218 SWITZERLAND: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 219 SWITZERLAND: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 220 SWITZERLAND: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 221 SWITZERLAND: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 222 SWITZERLAND: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 223 SWITZERLAND: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 224 SWITZERLAND: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 231
TABLE 225 SWITZERLAND: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 226 SWITZERLAND: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 227 SWITZERLAND: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 228 SWITZERLAND: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 229 SWITZERLAND: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 233
TABLE 230 SWITZERLAND: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 233

10.3.6 SPAIN 233
10.3.6.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth 233
TABLE 231 SPAIN: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 234
TABLE 232 SPAIN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 233 SPAIN: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 234 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 235 SPAIN: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 236 SPAIN: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 235
TABLE 237 SPAIN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 236
TABLE 238 SPAIN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 236
TABLE 239 SPAIN: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 236
TABLE 240 SPAIN: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 237
TABLE 241 SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 242 SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 243 SPAIN: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 238
TABLE 244 SPAIN: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 238
10.3.7 REST OF EUROPE 238
TABLE 245 ROE: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 239
TABLE 246 ROE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 239
TABLE 247 ROE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 240
TABLE 248 ROE: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 249 ROE: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 250 ROE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 240
TABLE 251 ROE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 241
TABLE 252 ROE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 241
TABLE 253 ROE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 241
TABLE 254 ROE: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 242
TABLE 255 ROE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 242
TABLE 256 ROE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 242
TABLE 257 ROE: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 243
TABLE 258 ROE: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 243
10.4 ASIA PACIFIC 244
FIGURE 29 APAC: BIOSURGERY MARKET SNAPSHOT 245
TABLE 259 ASIA PACIFIC: BIOSURGERY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 246
TABLE 260 ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 246
TABLE 261 ASIA PACIFIC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 262 ASIA PACIFIC: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 263 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 264 ASIA PACIFIC: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 265 ASIA PACIFIC: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 248
TABLE 266 ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 248
TABLE 267 ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 248
TABLE 268 ASIA PACIFIC: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 269 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 249
TABLE 270 ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 249
TABLE 271 ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 250
TABLE 272 ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 250
TABLE 273 ASIA PACIFIC: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 250
10.4.1 JAPAN 251
10.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan 251
TABLE 274 JAPAN: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 251
TABLE 275 JAPAN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 252
TABLE 276 JAPAN: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 252
TABLE 277 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 278 JAPAN: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 279 JAPAN: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 253
TABLE 280 JAPAN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 281 JAPAN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 254
TABLE 282 JAPAN: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 254
TABLE 283 JAPAN: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 254
TABLE 284 JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 255
TABLE 285 JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 255
TABLE 286 JAPAN: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 255
TABLE 287 JAPAN: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 256
10.4.2 CHINA 256
10.4.2.1 Growing number of hospitals and healthcare policy reforms stimulating the growth of the biosurgery market 256
TABLE 288 CHINA: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 257
TABLE 289 CHINA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 257
TABLE 290 CHINA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 257
TABLE 291 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 258
TABLE 292 CHINA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 258
TABLE 293 CHINA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 258
TABLE 294 CHINA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 295 CHINA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 259
TABLE 296 CHINA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 297 CHINA: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 260
TABLE 298 CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 260
TABLE 299 CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 260
TABLE 300 CHINA: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 261
TABLE 301 CHINA: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 261
10.4.3 INDIA 261
10.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India 261
TABLE 302 INDIA: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 262
TABLE 303 INDIA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 262
TABLE 304 INDIA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 263
TABLE 305 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 263
TABLE 306 INDIA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 263
TABLE 307 INDIA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 263
TABLE 308 INDIA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 264
TABLE 309 INDIA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 264
TABLE 310 INDIA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 264
TABLE 311 INDIA: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 312 INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 265
TABLE 313 INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 265
TABLE 314 INDIA: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 266
TABLE 315 INDIA: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 266
10.4.4 SOUTH KOREA 266
10.4.4.1 Growing number of cosmetic surgeries to drive the demand for surgical sealants and soft-tissue attachment products in South Korea 266
TABLE 316 SOUTH KOREA: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 267
TABLE 317 SOUTH KOREA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 267
TABLE 318 SOUTH KOREA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 267
TABLE 319 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 268
TABLE 320 SOUTH KOREA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 268
TABLE 321 SOUTH KOREA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 322 SOUTH KOREA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 269
TABLE 323 SOUTH KOREA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 269
TABLE 324 SOUTH KOREA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 269
TABLE 325 SOUTH KOREA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 270
TABLE 326 SOUTH KOREA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 270
TABLE 327 SOUTH KOREA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 270
TABLE 328 SOUTH KOREA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 271
TABLE 329 SOUTH KOREA: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 271
10.4.5 REST OF ASIA PACIFIC 271
TABLE 330 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 272
TABLE 331 REST OF ASIA PACIFIC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 272
TABLE 332 REST OF ASIA PACIFIC: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 272
TABLE 333 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 334 REST OF ASIA PACIFIC: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 273
TABLE 335 REST OF ASIA PACIFIC: SURGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 273
TABLE 336 REST OF ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 337 REST OF ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 274
TABLE 338 REST OF ASIA PACIFIC: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 339 REST OF ASIA PACIFIC: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 275
TABLE 340 REST OF ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 275
TABLE 341 REST OF ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 275
TABLE 342 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 276
TABLE 343 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 276
10.5 LATIN AMERICA 277
TABLE 344 LATIN AMERICA: BIOSURGERY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 277
TABLE 345 LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 277
TABLE 346 LATIN AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 347 LATIN AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 348 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 349 LATIN AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 279
TABLE 350 LATIN AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 351 LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 352 LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 280
TABLE 353 LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 280
TABLE 354 LATIN AMERICA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 280
TABLE 355 LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 281
TABLE 356 LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 281
TABLE 357 LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 281
TABLE 358 LATIN AMERICA: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 282
10.5.1 BRAZIL 282
10.5.1.1 Brazil accounted for the largest share of the LATAM market in 2020 282
TABLE 359 BRAZIL: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 282
TABLE 360 BRAZIL: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 282
TABLE 361 BRAZIL: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 362 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 363 BRAZIL: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 364 BRAZIL: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 283
TABLE 365 BRAZIL: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 366 BRAZIL: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 284
TABLE 367 BRAZIL: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 368 BRAZIL: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 369 BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 370 BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 285
TABLE 371 BRAZIL: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 286
TABLE 372 BRAZIL: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 286
10.5.2 MEXICO 286
10.5.2.1 Low-cost surgeries are driving medical tourism in Mexico 286
TABLE 373 MEXICO: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 287
TABLE 374 MEXICO: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 287
TABLE 375 MEXICO: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 287
TABLE 376 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 288
TABLE 377 MEXICO: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 288
TABLE 378 MEXICO: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 288
TABLE 379 MEXICO: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 289
TABLE 380 MEXICO: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 289
TABLE 381 MEXICO: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 289
TABLE 382 MEXICO: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 383 MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 384 MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 290
TABLE 385 MEXICO: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 291
TABLE 386 MEXICO: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 291
10.5.3 REST OF LATIN AMERICA 291
TABLE 387 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 292
TABLE 388 REST OF LATIN AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019–2026 (USD MILLION) 292
TABLE 389 REST OF LATIN AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 292
TABLE 390 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 293
TABLE 391 REST OF LATIN AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 293
TABLE 392 REST OF LATIN AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 293
TABLE 393 REST OF LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 294
TABLE 394 REST OF LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 294
TABLE 395 REST OF LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 294
TABLE 396 REST OF LATIN AMERICA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 295
TABLE 397 REST OF LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 295
TABLE 398 REST OF LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 295
TABLE 399 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 296
TABLE 400 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 296
10.6 MIDDLE EAST AND AFRICA 297
10.6.1 MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS 297
TABLE 401 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 297
TABLE 402 MIDDLE EAST AND AFRICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019–2026 (USD MILLION) 298
TABLE 403 MIDDLE EAST AND AFRICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 298
TABLE 404 MIDDLE EAST AND AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 298
TABLE 405 MIDDLE EAST AND AFRICA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 299
TABLE 406 MIDDLE EAST AND AFRICA: SURGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 299
TABLE 407 MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 299
TABLE 408 MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 300
TABLE 409 MIDDLE EAST AND AFRICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 300
TABLE 410 MIDDLE EAST AND AFRICA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 300
TABLE 411 MIDDLE EAST AND AFRICA: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 301
TABLE 412 MIDDLE EAST AND AFRICA: NATURAL ADHESION BARRIERS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 301
TABLE 413 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 301
TABLE 414 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 302
11 COMPETITIVE LANDSCAPE 303
11.1 OVERVIEW 303
11.2 KEY PLAYER STRATEGIES 304
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 305
11.4 MARKET SHARE ANALYSIS 305
11.4.1 SURGICAL SEALANTS AND ADHESIVES 305
FIGURE 31 SURGICAL SEALANTS AND ADHESIVES MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2020 305
11.4.2 HEMOSTATIC AGENTS 306
FIGURE 32 HEMOSTATIC AGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 306
11.4.3 BONE-GRAFT SUBSTITUTES 307
FIGURE 33 BONE-GRAFT SUBSTITUTES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 307
11.4.4 ADHESION BARRIERS 308
FIGURE 34 ADHESION BARRIERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 308
11.4.5 SOFT-TISSUE ATTACHMENTS 309
FIGURE 35 SOFT-TISSUE ATTACHMENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 309
11.5 COMPETITIVE BENCHMARKING 310
11.5.1 FOOTPRINT OF COMPANIES IN THE BIOSURGERY MARKET 310
TABLE 415 PRODUCT FOOTPRINT OF COMPANIES (25 MARKET PLAYERS) 311
TABLE 416 REGIONAL FOOTPRINT OF COMPANIES (25 MARKET PLAYERS) 312
11.6 COMPETITIVE LEADERSHIP MAPPING 314
11.6.1 STARS 314
11.6.2 EMERGING LEADERS 314
11.6.3 PERVASIVE PLAYERS 314
11.6.4 PARTICIPANTS 315
FIGURE 36 BIOSURGERY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 315
11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 316
11.7.1 PROGRESSIVE COMPANIES 316
11.7.2 DYNAMIC COMPANIES 316
11.7.3 STARTING BLOCKS 316
11.7.4 RESPONSIVE COMPANIES 316
FIGURE 37 BIOSURGERY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020) 317
11.8 COMPETITIVE SCENARIO 318
11.8.1 PRODUCT LAUNCHES & APPROVALS 318
11.8.2 DEALS 318
11.8.3 OTHER DEVELOPMENTS 319
12 COMPANY PROFILES 320
12.1 KEY PLAYERS 320
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BAXTER INTERNATIONAL INC. 320
TABLE 420 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW 320
FIGURE 38 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020) 321
12.1.2 B. BRAUN MELSUNGEN AG 325
TABLE 421 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 325
FIGURE 39 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 326
12.1.3 BECTON, DICKINSON & COMPANY 328
TABLE 422 BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW 328
FIGURE 40 BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020) 329
12.1.4 JOHNSON & JOHNSON 332
TABLE 423 JOHNSON & JOHNSON: BUSINESS OVERVIEW 332
FIGURE 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 333
12.1.5 MEDTRONIC PLC 337
TABLE 424 MEDTRONIC PLC: BUSINESS OVERVIEW 337
FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 338
12.1.6 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 341
TABLE 425 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW 341
FIGURE 43 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020) 342
12.1.7 COMMONWEALTH SERUM LABORATORIES LIMITED 345
TABLE 426 COMMONWEALTH SERUM LABORATORIES LIMITED: BUSINESS OVERVIEW 345
FIGURE 44 COMMONWEALTH SERUM LABORATORIES LIMITED: COMPANY SNAPSHOT (2020) 346
12.1.8 HEMOSTASIS LLC 347
TABLE 427 HEMOSTASIS LLC: BUSINESS OVERVIEW 347
12.1.9 PFIZER INC. 348
TABLE 428 PFIZER INC.: BUSINESS OVERVIEW 348
FIGURE 45 PFIZER INC.: COMPANY SNAPSHOT (2020) 349
12.1.10 STRYKER CORPORATION 350
TABLE 429 STRYKER CORPORATION: BUSINESS OVERVIEW 350
FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 351
12.1.11 CRYOLIFE, INC. 354
TABLE 430 CRYOLIFE, INC.: BUSINESS OVERVIEW 354
FIGURE 47 CRYOLIFE, INC.: COMPANY SNAPSHOT (2020) 355
12.1.12 ZIMMER BIOMET 357
TABLE 431 ZIMMER BIOMET: BUSINESS OVERVIEW 357
FIGURE 48 ZIMMER BIOMET: COMPANY SNAPSHOT (2020) 358
12.1.13 KUROS BIOSCIENCES AG 360
TABLE 432 KUROS BIOSCIENCES AG: BUSINESS OVERVIEW 360
FIGURE 49 KUROS BIOSCIENCES AG: COMPANY SNAPSHOT (2020) 361
12.1.14 ORTHOFIX MEDICAL INC. 363
TABLE 433 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW 363
FIGURE 50 ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT (2020) 364
12.1.15 SMITH & NEPHEW PLC 366
TABLE 434 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 366
FIGURE 51 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020) 367
12.1.16 TISSUE REGENIX GROUP PLC 368
TABLE 435 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW 368
FIGURE 52 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020) 368
12.1.17 BETATECH MEDICAL 371
TABLE 436 BETATECH MEDICAL: BUSINESS OVERVIEW 371
12.1.18 MERIL LIFE SCIENCES PVT. LTD. 373
TABLE 437 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW 373
12.1.19 RTI SURGICAL 374
TABLE 438 RTI SURGICAL: BUSINESS OVERVIEW 374
12.1.20 SAMYANG HOLDINGS CORPORATION 376
TABLE 439 SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW 376
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 378
12.2.1 AROA BIOSURGERY LTD. 378
12.2.2 MEYER-HAAKE GMBH 378
12.2.3 BIOM’UP 379
12.2.4 BIOCER ENTWICKLUNGS-GMBH 379
12.2.5 HANNOX INTERNATIONAL CORP. 380
13 APPENDIX 381
13.1 INSIGHTS OF INDUSTRY EXPERTS 381
13.2 DISCUSSION GUIDE 382
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 389
13.4 AVAILABLE CUSTOMIZATIONS 391
13.5 RELATED REPORTS 391
13.6 AUTHOR DETAILS 392

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[バイオ手術の世界市場予測(~2026年):製品種類別(シーラント、止血鉗子、接着バリア、軟組織アタッチメント、生物学的メッシュ、DBM、骨移植代替物)、用途別(整形手術、心臓血管)、エンドユーザー別(病院、クリニック)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆